1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "1175017-90-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-118304
    AKN-028

    FLT3 Caspase Cancer
    AKN-028 is an orally active and potent FLT3 tyrosine kinase inhibitor (IC50 = 6 nM). AKN-028 causes dose-dependent inhibition of FLT3 autophosphorylation.